<DOC>
	<DOCNO>NCT02588755</DOCNO>
	<brief_summary>The aim study compare outcomes Transarterial Chemoembolization ( TACE ) plus Tegafur TACE alone patient intrahepatic cholangiocarcinoma curative resection</brief_summary>
	<brief_title>TACE Plus Tegafur Versus TACE Intrahepatic Cholangiocarcinoma After Curative Resection</brief_title>
	<detailed_description />
	<mesh_term>Cholangiocarcinoma</mesh_term>
	<mesh_term>Chlorotrianisene</mesh_term>
	<mesh_term>Tegafur</mesh_term>
	<criteria>Male female patient &gt; 18 year &lt; =70 year age . Pathological evidence ICC Tumors completely resect . Criteria liver function : Child AB level , serum bilirubin ≤ 1.5 time upper limit normal value , alanine aminotransferase aspartate aminotransferase ≤ 2 time upper limit normal value . Patients understand trial sign information consent . Tumors resect . Patients apparent cardiac , pulmonary , cerebral renal dysfunction , may affect treatment Intrahepatic cholangiocarcinoma . Patients medical history malignant tumor . Subjects participate clinical trial . Liver function : Child C .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Chemoembolization</keyword>
	<keyword>Therapeutic</keyword>
	<keyword>Tegafur</keyword>
</DOC>